BMC Infectious Diseases (Oct 2024)

Clinical characteristics of pregnant women with COVID-19 and infection outcomes in one of the largest cities in the Brazilian Amazon

  • Ana Paula Figueiredo de Montalvão França,
  • Jenephy Thalita Rosa Paixão,
  • Ricardo Roberto de Souza Fonseca,
  • Rogério Valois Laurentino,
  • Luana Gabriella Figueiredo de Montalvão Leite,
  • Amanda Souza França Veras,
  • Francisco Jordano da Silva Feitosa Ribeiro,
  • Pablo Fabiano Moura das Neves,
  • Luís Fábio Magno Falcão,
  • Ana Carla Figueiredo de Montalvão Serrão,
  • Aldemir Branco Oliveira-Filho,
  • Luiz Fernando Almeida Machado

DOI
https://doi.org/10.1186/s12879-024-09982-x
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background Pregnancy can be a risk factor for the development of more severe COVID-19 with a possible increase in the risk of complications during pregnancy/birth and adverse neonatal outcomes. This study aimed to describe and analyze the clinical and epidemiological aspects of SARS-CoV-2 infection in women in the perinatal period attended in the city of Belém, northern region of Brazil. Methods This is a clinical, observational, analytical, and cross-sectional study with a quantitative approach, conducted at the Santa Casa de Misericórdia do Pará Foundation (FSCMPA). It included 230 pregnant women hospitalized at FSCMPA with a positive SARS-CoV-2 RT-PCR molecular test between April 2020 and June 2022. Clinical and epidemiological information (origin, gestational age, prenatal care, comorbidities, birth complications, and chest tomography) were obtained from medical records, and correlation was made between the types of cases (mild, moderate, and severe) and maternal outcome. The chi-square test and G test were used to assess the possibility of association between variables. Results Evidence of association was observed between the severity of COVID-19 and the following parameters: gestational age, specific pregnancy comorbidities, baby and maternal death, birth complications, and prematurity. Dyspnea, headache, anosmia, odynophagia, diarrhea, and chest pain were the symptoms most related to disease aggravation. The maternal mortality rate in the study was 8.7%. Conclusion Specific pregnancy-related and pre-existing comorbidities associated with SARS-CoV-2 infection directly contribute to the worsening clinical condition, leading to complications such as prematurity, fetal, and maternal death.

Keywords